$PULM Correct me if I’m wrote but even though FEND commission is 7-14% (14% starting next year), it’s not something insignificant 14% of all global revenue of fend , and pulm is not paying distribution expense, marketing expense, and production expense. And the market is completely obsolete and irresponsive to that? Company is also funded at least until Q4 2022 which is well into its results from Pulmazole which has a fast track ???? What the flying hell?